1. An oral immediate release composition comprising (i) a compound of general formula I: or a pharmaceutically acceptable salt, stereoisomer, hydrate, or tautomer, wherein: each of R are independently selected from alkoxy, alkyl, and hydrogen, each of R independently is selected from alkoxy , alkyl, halogen, and hydrogen R c is selected from alkyl, hydroxyl and alkoxy, with the proviso that if R is hydrogen, then R is alkoxy, with the proviso that if R is hydrogen, then R is alkoxy, with the proviso that when R c is selected from alkyl, gi Roxa and alkoxy, then at least one of R independently is selected from alkyl or alkoxy (ii) at least one glidant and (iii) at least one razryhlitel.2. Composition according to claim 1, characterized in that: each of R R is alkoxy each R of R is alkyl. iRvybran of alkoksi.3. Composition according to claim 2, characterized in that: each of R R is methoxy, each R of R is methyl. iRvybran of alkoxy, substituted gidroksilom.4. Composition according to claim. 3, characterized in that R is 2-gidroksietoksi.5. Composition according to claim. 1, characterized in that the active ingredient is 2- (4- (2-hydroxyethoxy) -3,5-dimethylphenyl) -5,7-dimethoxyquinazoline-4 (3H) -on.6. Composition according to claim. 1, characterized in that the active ingredient is a hydrochloride salt, 2- (4- (2-hydroxyethoxy) -3,5-dimethylphenyl) -5,7-dimethoxyquinazoline-4 (3H) -ona.7. Composition according to claim. 1, characterized in that at least one glidant is colloidal kremniya.8 dioxide. Composition according to claim. 1, characterized in that the particle size of the active ingredient varies within the range of zoom in Composition according to claim 2, characterized in that: each of R R is methoxy, each R of R is methyl. iRvybran of alkoxy, substituted gidroksilom.4. Composition according to claim. 3, characterized in that R is 2-gidroksietoksi.5. Composition according to claim. 1, characterized in that the active ingredient is 2- (4- (2-hydroxyethoxy) -
